Berbamine inhibits SARS-CoV-2 infection by compromising TRPMLs-mediated endolysosomal trafficking of ACE2
Lihong Huang(City University of Hong Kong), Jianbo Yue(Duke Kunshan University), Guoliang Zhang(Qingdao Agricultural University), Shuyan Liu(Shenzhen Third People’s Hospital), Terrence Tsz‐Tai Yuen(Sichuan University), Hin Chu(University of Hong Kong), Zuodong Ye(City University of Hong Kong)
Cited by 51
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility
|Clinical Infectious Diseases|2020|1.2k
Antibody evasion properties of SARS-CoV-2 Omicron sublineages
|Nature|2022|858